Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race

medRxiv(2025)10.1101/2025.01.21.25320918Source: DataRank Database

Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race is a research paper published in medRxiv (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: greenTopics (22)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Courtney E. Johnson ORCID,Mollie E. Barnard ORCID,Lindsay J. Collin ORCID,David A. Nix ORCID,Chad Huff

Live enrichment

PubMed:39974072 OpenAlex:https://openalex.org/W4406885070

NCI NIH HHS

Grant: R01 CA188943

NCI NIH HHS

Grant: K99 CA277580

NCI NIH HHS

Grant: R01 CA279065

NCI NIH HHS

Grant: R01 CA142081

NIH HHS

Grant: S10 OD021644

NCI NIH HHS

Grant: K00 CA212222

NCI NIH HHS

Grant: P30 CA042014

NIGMS NIH HHS

Grant: P20 GM104416

NIGMS NIH HHS

Grant: P20 GM130454

NCI NIH HHS

Grant: R01 CA237170

NCI NIH HHS

Grant: R01 CA200854

NCI NIH HHS

Grant: R01 CA076016

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2025/01/28/2025.01.21.25320918.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2025.01.21.25320918

repositoryhttps://doi.org/10.1101/2025.01.21.25320918

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39974072

Fields of Study

PARP inhibition in cancer therapyDNA Repair MechanismsBRCA gene mutations in cancer

Keywords

GermlineGermline mutationOvarian cancerSomatic cellHazard ratioOvarian carcinomaSerous fluidPopulationSerous carcinomaOncologyHomologous recombinationCancerInternal medicineBiologyMedicineGeneticsConfidence intervalMutationGene

Sustainable Development Goals

SDG 0: Good health and well-being